心血管疾病影像学新兴有前景的靶点
该综述概述了心血管分子影像示踪剂的最新进展,聚焦于靶向炎症、纤维化、代谢失调、血栓形成和血管重塑等机制的放射性药物。文中按机制靶点分类,总结了临床前与临床证据及转化挑战,指出这些示踪剂有望推动心血管疾病的影像驱动表型分型。
要点
- 传统影像无法在分子层面捕捉心血管疾病的病理生理机制。
- 新兴放射性药物可评估心肌纤维化、心肌细胞应激反应和代谢改变。
- 血栓、血管炎症、斑块不稳定性及细胞衰老等新靶点示踪剂正在开发中。
核心结论
- 这些示踪剂进展反映了向影像驱动的心血管疾病表型分型的范式转变。
- 综述按机制靶点对示踪剂分类,并强调其整合进精准心脏病学的潜力。
研究设计与样本
- 综述,检索范围未在摘要中具体说明。
主要发现
- 新兴放射性药物可评估心肌纤维化,例如胶原靶向和基质金属蛋白酶(MMP)靶向示踪剂。
- 新兴放射性药物可评估心肌细胞应激反应,例如氧化应激、未折叠蛋白反应和内皮素信号。
- 新兴放射性药物可评估代谢改变,例如脂肪酸、酮体和葡萄糖代谢。
- 正在开发用于血栓形成、血管炎症、斑块不稳定性以及细胞衰老和肠道来源炎症通路等创新靶点的新示踪剂。
关键数值与推荐
- 综述按机制靶点对示踪剂分类,并总结其生物学原理、临床前与临床证据及转化挑战。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, driven by complex and dynamic molecular processes such as inflammation, fibrosis, metabolic dysregulation, thrombosis, and vascular remodeling. While conventional imaging techniques provide valuable anatomical and functional information, they fail to capture these underlying pathophysiological mechanisms at the molecular level. Molecular imaging, particularly with PET and SPECT, offers the potential to noninvasively visualize and quantify these processes, enabling earlier diagnosis, better risk stratification, and more precise treatment guidance. Despite substantial progress in clinical cardiology, there is a growing need for novel radiotracers that can target key disease-driving mechanisms beyond traditional perfusion or viability imaging. Emerging radiopharmaceuticals now enable the assessment of myocardial fibrosis (e.g., collagen-targeted and MMP-targeted tracers), cardiomyocyte stress responses (e.g., oxidative stress, unfolded protein response, endothelin signaling), and metabolic alterations (e.g., fatty acid, ketone, and glucose metabolism). Additionally, new tracers are being developed for thrombosis, vascular inflammation, plaque instability, and even for innovative targets such as cellular senescence and gut-derived inflammatory pathways. These developments reflect a paradigm shift towards imaging-driven phenotyping of cardiovascular disease. This review provides a comprehensive overview of the latest advances in molecular imaging tracers for cardiovascular applications, with a focus on their biological rationale, preclinical and clinical evidence, and translational challenges. We categorize tracers by their mechanistic targets and highlight their potential for integration into precision cardiology.
引用
- Ståhle M, Popescu C, Rischpler C, et al. New Promising Targets for Imaging in Cardiovascular Diseases. Semin Nucl Med. 2025. PMID: 40555628. doi:10.1053/j.semnuclmed.2025.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。